News
4317 posts · page 4 of 180
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is reportedly negotiating a $1 billion purchase of Sofie Biosciences, a leader in cancer scan chemicals.
Molbio Diagnostics Reports Rs 52.7 Cr Profit in Q1 Post-IPO
Molbio Diagnostics turned a profit of Rs 52.74 crore in Q1, reversing a loss from the previous year, buoyed by strong Truenat test-kit sales.
Indian AI Platform iOncology.ai Gains Spotlight in BRICS Health Journal
iOncology.ai, an AI cancer care platform, is featured in the BRICS Health Journal, highlighting India's innovation in healthcare technology.
Waystar Considers Sale as Market Value Slumps Amid Software Sector Decline
Waystar explores strategic options, including a potential sale, after a significant drop in market value.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is reportedly negotiating a $1 billion acquisition of Sofie Biosciences to enhance its diagnostics division.
Biotechnology and AI: Navigating New Opportunities and Responsibilities
The convergence of biotechnology and AI presents unprecedented opportunities and ethical challenges.
New Frontier in Protein Secretion: Synthetic Switches in Cells
Researchers explore unconventional protein secretion as a design tool for synthetic biology, expanding beyond traditional ER-Golgi pathways.
New IGZO Biosensor Platform Enhances Stability, Detects Cortisol
A breakthrough IGZO biosensor offers improved mechanical stability and precise cortisol detection, advancing flexible electronics.
Innovative Biosensor Transforms Molecular Signals into Visual Data
A new biosensor converts molecular signals into images, eliminating the need for traditional spectrometers.
Point-of-Care Diagnostics Market Poised for Growth by 2035
The point-of-care diagnostics market is set for significant expansion by 2035, driven by technological advancements and increased demand.
Rising Demand for Carbon Monoxide Sensors in Healthcare by 2035
The carbon monoxide sensor market is expanding, driven by healthcare needs in patient monitoring and surgical safety.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 After IPO
Molbio Diagnostics achieved a Rs 52.7 crore profit in Q1, rebounding from a loss last year, driven by strong Truenat test-kit sales.
Indian AI Platform iOncology.ai Gains Spotlight in BRICS Health Journal
iOncology.ai, developed by AIIMS and C-DAC, is featured in the BRICS Health Journal, showcasing its potential to transform cancer care in emerging economies.
Waystar Considers Sale Amid Declining Market Value
Waystar is exploring strategic options, including a potential sale, following a significant drop in its market value.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is negotiating a $1 billion acquisition of Sofie Biosciences, a leader in cancer scan chemicals.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 Post-IPO
Molbio Diagnostics announced a Rs 52.7 crore profit for Q1, reversing last year's loss, following its recent IPO.
iOncology.ai: India's AI Platform for Cancer Care Gains BRICS Spotlight
iOncology.ai, developed by AIIMS and C-DAC, is featured in BRICS Health Journal for its role in transforming cancer care.
Waystar Weighs Sale Amid Falling Valuations in Software Sector
Waystar, a healthcare software firm, is exploring a sale with Evercore's guidance, sources reveal.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is negotiating a $1 billion deal to acquire Sofie Biosciences, enhancing its diagnostics division.
Molbio Diagnostics Reports Rs 52.7 Cr Profit in Q1 After IPO Success
Molbio Diagnostics posted a Rs 52.7 crore profit in Q1, rebounding from a loss last year, buoyed by strong Truenat test-kit sales.
Indian AI Platform iOncology.ai Showcased in BRICS Health Journal
iOncology.ai, developed by AIIMS and C-DAC, aims to enhance cancer care in emerging economies and is highlighted at the BRICS Summit.
Waystar Considers Sale Amid Declining Valuation, Sources Reveal
Healthcare software firm Waystar may be up for sale, with Evercore advising. Its market value has dropped following a 24% share price fall.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is reportedly in talks to acquire radiopharmaceutical firm Sofie Biosciences for $1 billion, enhancing its cancer diagnostics capabilities.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 Post-IPO
Molbio Diagnostics records Rs 52.7 crore profit in Q1, reversing last year's loss. Truenat test-kits drive growth.